FindMyKOL
Clinical trialNCT01200875CompletedObservational

Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections

NCT01200875 is an observational study sponsored by Stanford University. As of 21 Nov 2026, it is completed. It studies Rheumatic Diseases and Tendinopathy. The registry lists an enrollment of 25 participants at 1 site in 1 country. The registry lists a start date of 31 Jul 2010 and a primary completion date of 31 Dec 2011.

SponsorStanford University →Enrollment25Rheumatic DiseasesTendinopathy
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01200875
FieldValue
Registry IDNCT01200875
StatusCompleted
Study typeObservational study
Lead sponsorStanford University
Enrollment25
Registered sites1
Countries1
ConditionsRheumatic Diseases and Tendinopathy
Start31 Jul 2010
Primary completion31 Dec 2011
Study completion31 May 2013
Last update posted6 Aug 2018

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Platelet-Rich Plasma (PRP) has been banned in competitive athletes because some people think it may enhance athletic performance. However, there is very little published research to support or undermine this point of view. The purposes of this study are: (1) To assess the effects of local platelet-rich plasma (PRP) therapy on systemic levels of growth factors with suspected or known performance-enhancing effects; and (2) To understand whether the effect of PRP therapy on these growth factors differs between intramuscular and intratendinous PRP injections. This research study is looking for 40 people who are receiving platelet-rich plasma therapy for a tendon or muscle injury. The study involves collecting seven blood samples (2 teaspoons each) from each patient, before and after the PRP treatment. Blood samples may be donated at any location of the patient's choosing, and participants will be paid for their time.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site
  • New York University Langone Orthopedic Hospital

    New York

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01200875

Each answer restates registry values shown on this page.

What is NCT01200875?

NCT01200875 is an observational study sponsored by Stanford University. It studies Rheumatic Diseases and Tendinopathy.

Who leads NCT01200875?

The registry names Dr. Christina Herrero (study director, New York University Langone Orthopedic Hospital) and Dr. Jason L. Dragoo (principal investigator, Stanford University) as overall officials.

Where does NCT01200875 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01200875 end?

The registry lists a primary completion date of 31 Dec 2011 and a study completion date of 31 May 2013. The sponsor last updated the record on 6 Aug 2018.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.